Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
The Oncologist
|
January 6, 2005
Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management
F Couture, A R Turner, B Melosky, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 17, 2007
Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department
Sheryl B Lyss, Bernard M Branson, Karen A Kroc, et al.
Experimental Hematology
|
March 1, 1993
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation
M Crump, F Couture, M Kovacs, et al.
Bone Marrow Transplantation
|
November 17, 2009
Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group
J Kuruvilla, M Pintilie, D Stewart, et al.
Journal of Pain and Symptom Management
|
December 1, 2001
Epoetin alfa in cancer patients: evidence-based guidelines
R Turner, P Anglin, R Burkes, et al.
Psycho-Oncology
|
June 19, 2008
The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer
H G Mar Fan, A Park, W Xu, et al.
Journal of Biotechnology
|
September 23, 2000
Candidate Neisseria meningitidis NspA vaccine
D Martin, B R Brodeur, J Hamel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy
I Quirt, C Robeson, C Y Lau, et al.
Leukemia & Lymphoma
|
August 10, 1999
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomas
P Goss, A K Stewart, F Couture, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant
M Crump, A M Smith, J Brandwein, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
The Oncologist
|
January 6, 2005
Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management
F Couture, A R Turner, B Melosky, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 17, 2007
Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department
Sheryl B Lyss, Bernard M Branson, Karen A Kroc, et al.
Experimental Hematology
|
March 1, 1993
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation
M Crump, F Couture, M Kovacs, et al.
Bone Marrow Transplantation
|
November 17, 2009
Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group
J Kuruvilla, M Pintilie, D Stewart, et al.
Journal of Pain and Symptom Management
|
December 1, 2001
Epoetin alfa in cancer patients: evidence-based guidelines
R Turner, P Anglin, R Burkes, et al.
Psycho-Oncology
|
June 19, 2008
The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer
H G Mar Fan, A Park, W Xu, et al.
Journal of Biotechnology
|
September 23, 2000
Candidate Neisseria meningitidis NspA vaccine
D Martin, B R Brodeur, J Hamel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy
I Quirt, C Robeson, C Y Lau, et al.
Leukemia & Lymphoma
|
August 10, 1999
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomas
P Goss, A K Stewart, F Couture, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant
M Crump, A M Smith, J Brandwein, et al.
Page
of 4